OTHER GROUP COMPANIES
market

GlaxoSmithKline Pharma completes sale of manufacturing facility at Vemgal, Karnataka

The current market cap of the company is Rs29,240.33cr.

December 21, 2021 9:20 IST | India Infoline News Service
GlaxoSmithKline Pharmaceuticals Limited has informed to the exchanges regarding completion of sale of company's manufacturing facility.

As per regulatory filing, "Company has completed the transaction relating to sale of the Company’s business undertaking i.e., manufacturing facility together with the land, plant and machinery, assets, software and equipment located at Vemgal, Karnataka to Hetero Labs Limited", said pharma industry on Monday.

At around 9:20 AM, Glaxosmithkline Pharmaceuticals was trading at Rs1,747.50 apiece up by Rs21.45 or 1.24%.

Previosuly, the scrip ended at Rs1,726.05 apiece on the BSE.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity